Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index fell nearly 3 percent in April, posting its first loss for 2019 amid wider losses for biotech stocks.

The index underperformed the Dow Jones Industrial Average and the Nasdaq, which gained nearly 3 percent and nearly 5 percent, respectively, but outperformed the Nasdaq Biotechnology Index, which fell nearly 5 percent. Individual stock performance in the April GenomeWeb Index was mostly negative as 17 of the 30 stocks saw losses and 13 saw gains.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.